Record title

Ibrutinib (ImbruvicaTM) potently inhibits ErbB receptor phosphorylation and cell viability of ErbB2-positive breast cancer cells

Record identifier

TN_cdi_proquest_miscellaneous_1623288561

https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1623288561

Ibrutinib (ImbruvicaTM) potently inhibits ErbB receptor phosphorylation and cell viability of ErbB2-positive breast cancer cells

About this item

Full title

Ibrutinib (ImbruvicaTM) potently inhibits ErbB receptor phosphorylation and cell viability of ErbB2-positive breast cancer cells

Publisher

New York: Springer US

Journal title

Investigational new drugs, 2014, Vol.32 (6), p.1096-1104

Record Identifier

TN_cdi_proquest_miscellaneous_1623288561

Language

English

Formats

Publication information

Publisher

More information

Scope and Contents

Contents

Alternative Titles

Full title

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1623288561

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1623288561

Other Identifiers

ISSN

E-ISSN

DOI

How to access this item